- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04645654
Brief Postoperative Hypnosis Intervention as Multimodal Analgesia After Major Abdominal Surgery (Hypn+ERAS)
A Randomized-controlled Clinical Trial of Brief Postoperative Hypnosis Intervention as Multimodal Analgesia After Major Abdominal Surgery in the ERAS Protocol
This study will measure the efficacy of hypnosis on pain after a major abdominal surgery. The aim is to further improve comfort and rehabilitation of patients after surgery, beyond the usual early recovery after surgery (ERAS) enhancement protocols.
Patients will be randomised (1:2) to the standard of care regarding pain management and rehabilitation, as part of the ERAS protocol, vs. ERAS + an additional hypnosis intervention. In this group, hospitalised patients are given 3 hypnosis sessions targeting analgesia between postoperative day 1 to 12.
The study will collect outcomes about pain and its burden, sleep quality, appetite, mobilisation and mood. Secondary outcomes also include use of pain medication and length of hospital stay.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary objective of the present study is to evaluate the efficacy of hypnosis as an adjunct to the standard of care pain management program on postoperative pain compared to the standard ERAS program. Our hypothesis is that hypnosis, as part of a multi-modal analgesic management plan, will lead to decreased levels of pain compared to standard of care.
A secondary hypothesis is that better controlled pain will lead to enhanced recovery, in terms of post-operative incidence of complications, physical comfort and independence, psychological and emotional state and length of stay.
This study is an open label randomized controlled trial with two arms, comparing hypnosis as adjunctive therapy vs. standard of care. It is a monocentric study and will take place at Centre Hospitalier Universitaire Vaudois (CHUV), a teaching hospital in Lausanne, Switzerland. It represents a collaboration between the Service of Visceral Surgery and the Center of Integrative and Complementary Medicine.
Participants will be recruited before a planned surgery, as well as in the post-surgical setting. They will be screened by the study team to ensure they fulfil the inclusion criteria. If eligible and after informed consent is obtained, an assessment of the cognitive function will be performed (cf. Chapter 4: study population). All included participants will then be randomized in a 2:1 proportion to the "Hypnosis (H)" group or the "Standard of Care (SOC)" group.
After major abdominal surgery, all participants will benefit from a standard ERAS recovery program. The ERAS protocol involves multimodal pain management with medications, interventional pain therapy as needed, and psychological support if needed.
Relevance:
Acute pain has a major impact on LOS after surgery due to delayed recovery and opioid side effects. Furthermore, acute pain represents a risk for chronic pain, with its massive impact on quality of life and function. Interest is growing for non-pharmacological interventions as part of a multimodal approach for acute pain management. Hypnosis could be a low risk, cost-effective complementary therapy to improve patients' pain management, with possible impact on recovery and eventually a reduction of the length of hospital stay after surgery. If hypnosis is demonstrated to be an effective way to improve post-operative pain management in fragile patients undergoing massive abdominal surgery, then this therapy could be offered more broadly as adjunction to the actual standard of care in our teaching hospital.
Furthermore, the Department of Visceral Surgery at CHUV is a teaching ward, accredited by the ERAS society. Therefore, results may be used to improve patient care within the ERAS society more broadly.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chantal Berna
- Phone Number: +41213142040
- Email: chantal.berna-renella@chuv.ch
Study Locations
-
-
Vaud
-
Lausanne, Vaud, Switzerland, 1011
- Centre de Médecine Intégrative et Complémentaire, CHUV
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Female and male adults (from 18 years old).
- Major abdominal surgery with planned hospitalisation of more than seven days post-operatively, according to clinician's evaluation
- Able to give informed consent as documented by signature
- Interested in trying hypnosis as a complementary pain management therapy
Exclusion Criteria:
- Inability to engage in the intervention of the study, e.g. inability to communicate in French without a translator, cognitive impairment, severe hearing impairment
- Acute psychiatric (e.g. psychotic or suicidal ideation) or somatic (e.g. unstable cardio-respiratory condition) co-morbidity preventing full engagement during intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hypnosis
3 sessions of script-based hypnosis (analgesic suggestions) + recordings provided for self-hypnosis
|
Three sessions of 30 minute hypnosis, based on standardised script, focused on pain management.
|
No Intervention: Standard of care
Standard of care ERAS based optimized multimodal analgesia, without any complementary medicine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity at mobilisation
Time Frame: Between postoperative day 1 to 12.
|
visual analogue pain intensity scale from 0 (no pain) to 10 (most intense pain imaginable)
|
Between postoperative day 1 to 12.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity at rest
Time Frame: Between postoperative day 1 to 12.
|
visual analogue pain scale from 0 (no pain) to 10 (most intense pain imaginable)
|
Between postoperative day 1 to 12.
|
Pain unpleasantness
Time Frame: Between postoperative day 1 to 12.
|
visual analogue scale from 0 (not unpleasant) to 10 (most unpleasant pain imaginable)
|
Between postoperative day 1 to 12.
|
Opioid consumption
Time Frame: Between postoperative day 1 to 12
|
opioid name and dose (mg) recorded in medical chart
|
Between postoperative day 1 to 12
|
Post-surgical complications
Time Frame: Between postoperative day 1 to 12
|
list of complications recorded in patient's medical chart
|
Between postoperative day 1 to 12
|
Length of hospital stay
Time Frame: through study completion; records checked up to 100 days after end of study participation
|
date of entry to date of release from the hospital
|
through study completion; records checked up to 100 days after end of study participation
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chantal Berna, Prof, Centre de Médecine Intégrative et Complémentaire, CHUV
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CER-VD 2020-01710
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Pain
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Hypnosis
-
Central Hospital, Nancy, FranceRecruitingCancer | Alzheimer Disease | Myocarditis | ParkinsonFrance
-
University of AarhusAarhus University HospitalCompleted
-
Rennes University HospitalCompleted
-
Centre Hospitalier Intercommunal CreteilRecruiting
-
Hospital St. Joseph, Marseille, FranceRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedUsing Virtual Reality to Prevent Pre-operative Anxiety in Ambulatory Surgery Patients (PACAH-UCA HV)Surgery | Hallux ValgusFrance
-
University of WashingtonNational Multiple Sclerosis SocietyCompleted
-
Lone Knudsen, MSc Psych, PhDTerminated
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States